rs28936703

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_003865.3(HESX1):​c.509C>T​(p.Ser170Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000608 in 1,613,136 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

HESX1
NM_003865.3 missense

Scores

4
12
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:2U:3

Conservation

PhyloP100: 5.80

Publications

8 publications found
Variant links:
Genes affected
HESX1 (HGNC:4877): (HESX homeobox 1) This gene encodes a conserved homeobox protein that is a transcriptional repressor in the developing forebrain and pituitary gland. Mutations in this gene are associated with septooptic dysplasia, HESX1-related growth hormone deficiency, and combined pituitary hormone deficiency. [provided by RefSeq, Jul 2008]
HESX1 Gene-Disease associations (from GenCC):
  • septooptic dysplasia
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypothyroidism due to deficient transcription factors involved in pituitary development or function
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HESX1NM_003865.3 linkc.509C>T p.Ser170Leu missense_variant Exon 4 of 4 ENST00000295934.8 NP_003856.1 Q9UBX0A1LQR0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HESX1ENST00000295934.8 linkc.509C>T p.Ser170Leu missense_variant Exon 4 of 4 1 NM_003865.3 ENSP00000295934.3 Q9UBX0
HESX1ENST00000647958.1 linkc.509C>T p.Ser170Leu missense_variant Exon 7 of 7 ENSP00000498190.1 Q9UBX0
HESX1ENST00000473921.2 linkc.407C>T p.Ser136Leu missense_variant Exon 3 of 3 5 ENSP00000418918.1 C9J0A9

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152040
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000358
AC:
9
AN:
251076
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.0000704
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000657
AC:
96
AN:
1460978
Hom.:
0
Cov.:
30
AF XY:
0.0000688
AC XY:
50
AN XY:
726786
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33460
American (AMR)
AF:
0.00
AC:
0
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39552
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86168
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000810
AC:
90
AN:
1111466
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152158
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41516
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67988
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000752
Hom.:
0
Bravo
AF:
0.0000189
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

SEPTOOPTIC DYSPLASIA, MILD Pathogenic:1
Jan 01, 2001
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

HESX1-related disorder Pathogenic:1
Mar 14, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The HESX1 c.509C>T variant is predicted to result in the amino acid substitution p.Ser170Leu. This variant was reported in multiple heterozygous individuals with isolated growth hormone deficiency, one of whom also had optic hypoplasia (Parks et al 1999. PubMed ID: 10599689; Brickman et al. 2001. PubMed ID: 11748154). This variant was also reported in a heterozygous individual with ventriculomegaly, partial agenesis of the corpus collosum, cavum septum pellucidum, adrenal gland agenesis, aplasia/hypoplasia of the optic tract, and optic nerve aplasia (Marangoni et al. 2021. PubMed ID: 34906519). Results of DNA binding assays suggest the p.Ser170Leu variant in heterozygous individuals is functionally compromised (Thomas et al. 2001. PubMed ID: 11136712; Brickman et al. 2001. PubMed ID: 11748154). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. -

not provided Uncertain:1
Oct 26, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Septo-optic dysplasia sequence;C2750027:GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES Uncertain:1
Aug 17, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects HESX1 function (PMID: 11136712, 11748154). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 7692). This missense change has been observed in individual(s) with clinical features of autosomal dominant septo-optic dysplasia (PMID: 11136712, 11748154, 17148560, 34906519). This variant is present in population databases (rs28936703, gnomAD 0.006%). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 170 of the HESX1 protein (p.Ser170Leu). -

Septo-optic dysplasia sequence Uncertain:1
Oct 10, 2023
University of Washington Department of Laboratory Medicine, University of Washington
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Ser170Leu variant in the HESX1 gene has been previously reported in multiple unrelated individuals with clinical features of autosomal dominant HESX1-related disorders, including isolated growth hormone deficiency (Parks 1999, Brickman 2001, Thomas 2001). The p.Ser170Leu variant has been submitted to ClinVar (Variation ID: 7692, ncbi.nlm.nih.gov/clinvar/), and has been identified in 9/251076 (v4.0.0: 98/1613136) chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This allele frequency is low enough to be consistent with a milder hypomorphic allele. In silico tools predict that the p.Ser170Leu variant is deleterious. Functional studies of this variant are supportive of a deleterious effect to the protein; however, it is unclear if this would be sufficient to be disease-causing (Brickman 2001, Thomas 2001). Using ACMG guidelines, this variant was classified as a variant of uncertain significance (ACMG evidence codes used: PS3_moderate, PS4_supporting). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.22
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;D;T
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
.;D;D
M_CAP
Uncertain
0.10
D
MetaRNN
Uncertain
0.67
D;D;D
MetaSVM
Uncertain
0.79
D
MutationAssessor
Benign
1.1
L;L;.
PhyloP100
5.8
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-3.2
.;D;D
REVEL
Pathogenic
0.72
Sift
Uncertain
0.0010
.;D;D
Sift4G
Uncertain
0.035
.;D;D
Polyphen
0.97
D;D;.
Vest4
0.51, 0.89
MVP
0.97
MPC
0.20
ClinPred
0.64
D
GERP RS
4.6
Varity_R
0.30
gMVP
0.55
Mutation Taster
=9/91
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28936703; hg19: chr3-57232274; API